Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$229K Buy
1,504
+511
+51% +$85.1K 0.04% 428
2026
Q1
$208K Buy
+993
New +$250K 0.05% 306
2025
Q3
Sell
-750
Closed -$236K 643
2025
Q2
$236K Sell
750
-208
-22% -$60K 0.04% 419
2025
Q1
$252K Buy
+958
New +$259K 0.05% 360

Other funds holding PODD

111 Capital's PODD Position: Q2 2026 in Review

111 Capital increased its Insulet (PODD) stake by 51% in Q2 2026, buying an estimated $85.1K and bringing the position to 1,504 shares worth $229K. The position accounts for 0.04% of the portfolio, ranked #428.

111 Capital first reported a position in PODD in Q1 2025 and has held it in 4 quarters since. The position peaked at $252K in Q1 2025. 722 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • 111 Capital held 1,504 shares of Insulet worth $229K as of Q2 2026.
  • 111 Capital bought 511 Insulet shares in Q2 2026, an estimated $85.1K.
  • Insulet made up 0.04% of 111 Capital's portfolio in Q2 2026, its #428 holding.
  • 111 Capital first reported a position in Insulet in Q1 2025 and has held it in 4 quarters since.
  • 111 Capital's Insulet position peaked at $252K in Q1 2025.
  • 722 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on 111 Capital's 13F filing for Q2 2026, filed 5 Aug 2026.